Report - Ascentage PharmaGroup€¦ · Global Clinical Development for Major Oncology Opportunities Ascentagereceived 21 IND approvals globally •APG-2575(CLL/SLL,WM) •APG-1252(SCLC, NSCLC,

Please pass captcha verification before submit form